QQ客服 官方微博 反馈留言

	Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells
	Wang, Ying; Xu, Yingxi; Li, Saisai; Liu, Jia; Xing, Yanyan; Xing, Haiyan; Tian, Zheng; Tang, Kejing; Rao, Qing; Wang, Min
	2018
卷号	11期号:1页码:60
关键词	Acute myeloid leukemia Chimeric antigen receptor FLT3 FLT3-ITD Immunotherapy
ISSN号	1756-8722
DOI	10.1186/s13045-018-0603-7
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6359289
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Wang, Ying,Xu, Yingxi,Li, Saisai,et al. Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells[J],2018,11(1):60.
APA	Wang, Ying.,Xu, Yingxi.,Li, Saisai.,Liu, Jia.,Xing, Yanyan.,...&Wang, Jianxiang.(2018).Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.,11(1),60.
MLA	Wang, Ying,et al."Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells".11.1(2018):60.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。